StonvexLoading…
StonvexStonvexStonvexCore line items from FN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-27 | Annual 2024 2024-06-28 | Annual 2023 2023-06-30 | Annual 2022 2022-06-24 |
|---|---|---|---|---|
Revenue | $3.42B | $2.88B | $2.65B | $2.26B |
Operating Income | $324.45M | $277.61M | $251.70M | $204.52M |
Net Income | $332.53M | $296.18M | $247.91M | $200.38M |
EPS (Diluted) | $9.17 | $8.10 | $6.73 | $5.36 |
Total Assets | $2.83B | $2.34B | $1.98B | $1.84B |
Total Liabilities | $849.62M | $592.77M | $510.99M | $581.96M |
Cash & Equivalents | $306.43M | $409.97M | $231.37M | $198.00M |
Free Cash Flow OCF − CapEx | $207.29M | $365.62M | $151.95M | $34.66M |
Shares Outstanding | 35.73M | 36.15M | 36.18M | 36.44M |